THC
Tenet Healthcare Corporation
$174.79
+$1.01(+0.58%)
47
Overall
75
Value
18
Tech
50
Quality
Market Cap
$17.67B
Volume
409.27K
52W Range
$146.60 - $247.21
Target Price
$247.10
Order:
Income Statement
| Metric | Trend | Chart | 2016 Dec | 2017 Dec | 2018 Dec | 2019 Dec | 2020 Dec | 2021 Dec | 2022 Dec | 2023 Dec | 2024 Dec | 2025 Dec |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| REVENUE | ||||||||||||
| Total Revenue | $21.1B | $20.6B | $18.3B | $18.5B | $17.6B | $19.5B | $19.2B | $20.5B | $20.7B | $21.3B | ||
| Total Revenue | $21.1B | $20.6B | $18.3B | $18.5B | $17.6B | $19.5B | $19.2B | $16.0M | $20.7B | $21.3B | ||
| COST OF GOODS SOLD | ||||||||||||
| Cost of Revenue | $3.3B | $541.0M | $-127.0M | $-15.0M | $3.0B | $3.3B | $3.3B | -- | $3.6B | -- | ||
| GROSS PROFIT | ||||||||||||
| Gross Profit | $17.7B | $20.1B | $127.0M | $15.0M | $14.7B | $16.2B | $15.9B | $16.0M | $20.7B | $21.3B | ||
| OPERATING EXPENSES | ||||||||||||
| Operating Expenses | $16.3B | $19.1B | $16.9B | $16.6B | $16.1B | $17.2B | $17.0B | $17.3B | $16.9B | $17.9B | ||
| Selling, General & Administrative | -- | $3.1B | $3.0B | $3.1B | $3.0B | $3.3B | $3.3B | $3.6B | $3.6B | $3.8B | ||
| Selling & Marketing Expenses | -- | -- | -- | $3.1B | $3.0B | $3.3B | $3.3B | $3.6B | $3.6B | $3.8B | ||
| General & Administrative Expenses | $-335.0M | $3.1B | $3.0B | -- | -- | -- | -- | -- | -- | -- | ||
| Salaries & Wages | $9.1B | $9.1B | $8.8B | $8.5B | $8.1B | $8.8B | $8.8B | $9.1B | $8.8B | $8.7B | ||
| Depreciation & Amortization | $850.0M | $870.0M | $802.0M | $850.0M | $857.0M | $855.0M | $841.0M | -- | -- | -- | ||
| Depreciation & Amortization | $850.0M | $870.0M | $802.0M | $850.0M | $857.0M | $855.0M | $841.0M | -- | -- | $863.0M | ||
| Amortization | $-140.0M | $-182.0M | $-196.0M | $7.3B | $8.9B | $9.3B | $10.2B | -- | -- | -- | ||
| Other Operating Expenses | $6.3B | $6.0B | $4.3B | $4.2B | $4.1B | $4.2B | $4.0B | $4.5B | $4.5B | $4.5B | ||
| OPERATING INCOME | ||||||||||||
| Operating income | $1.4B | $992.0M | $-16.8B | $1.5B | $2.0B | $2.9B | $2.3B | $2.5B | $6.0B | $3.5B | ||
| EBITDA | $2.1B | $1.8B | $2.5B | $2.2B | $2.5B | $3.7B | $3.1B | $3.4B | $6.9B | $4.5B | ||
| NON-OPERATING ITEMS | ||||||||||||
| Interest Expense (Non-Operating) | $979.0M | $1.0B | $1.0B | $985.0M | $1.0B | $923.0M | $890.0M | $901.0M | $826.0M | $821.0M | ||
| Net Non-Operating Interest Income/Expense | $-979.0M | $-1.0B | $-1.0B | $-985.0M | $-1.0B | $-923.0M | $-890.0M | $-901.0M | $-826.0M | $-821.0M | ||
| Gain on Sale of Securities | $8.0M | -- | -- | -- | -- | -- | $1.0M | -- | -- | -- | ||
| Other Income/Expense | $-111.0M | $42.0M | $-146.0M | $57.0M | $-736.0M | $-349.0M | $-178.0M | $618.0M | $440.0M | $-377.0M | ||
| Other Special Charges | $-20.0M | $-186.0M | $-4.0M | $-232.0M | $567.0M | $131.0M | $95.0M | $24.0M | $118.0M | $113.0M | ||
| SPECIAL ITEMS | ||||||||||||
| Restructring And Mn A Income | $-202.0M | $-541.0M | $-115.0M | $137.0M | $184.0M | $57.0M | $118.0M | $870.0M | -- | -- | ||
| Special Income Charges | $-293.0M | $-23.0M | $-38.0M | $-141.0M | $-44.0M | $-116.0M | $-70.0M | $-47.0M | $-35.0M | $-64.0M | ||
| Impairment of Capital Assets | -- | $-402.0M | $-77.0M | $42.0M | $92.0M | $8.0M | $94.0M | -- | -- | -- | ||
| PRE-TAX INCOME | ||||||||||||
| EBIT | $1.2B | $927.0M | $1.6B | $1.3B | $1.7B | $2.8B | $2.2B | $2.5B | $6.1B | $3.6B | ||
| Pre-Tax Income | $248.0M | $-101.0M | $629.0M | $320.0M | $671.0M | $1.9B | $1.3B | $1.7B | $2.4B | $2.9B | ||
| INCOME TAX | ||||||||||||
| Tax Provision | $67.0M | $219.0M | $176.0M | $160.0M | $-97.0M | $411.0M | $344.0M | $306.0M | $1.2B | $433.0M | ||
| NET INCOME | ||||||||||||
| Net Income | $-192.0M | $-704.0M | $-18.2B | $-215.0M | $399.0M | $914.0M | $411.0M | $611.0M | $3.2B | $1.4B | ||
| Net Income (Continuing Operations) | $-192.0M | $-704.0M | $-18.2B | $-215.0M | $399.0M | $914.0M | $1.0B | $1.3B | $4.1B | $2.4B | ||
| Net Income (Discontinued Operations) | $-192.0M | $-704.0M | $-18.2B | $-215.0M | $399.0M | $914.0M | $411.0M | $611.0M | $3.2B | $1.4B | ||
| Net Income (Common Stockholders) | $-192.0M | $-704.0M | $-18.2B | $-215.0M | $399.0M | $914.0M | $411.0M | $611.0M | $3.2B | $1.4B | ||
| Normalized Income | -- | -- | -- | -- | -- | -- | $1.4B | -- | -- | $3.0B | ||
| TOTALS | ||||||||||||
| Total Expenses | $19.7B | $19.6B | $16.8B | $16.6B | $16.1B | $17.6B | $20.2B | $17.3B | $16.9B | $17.9B | ||
| SHARE & EPS DATA | ||||||||||||
| Average Shares Outstanding | $99.3M | $100.6M | $102.1M | $103.4M | $105.0M | $106.8M | $106.9M | $101.6M | $96.9M | $90.2M | ||
| Average Shares Outstanding (Diluted) | $99.3M | $100.6M | $103.9M | $103.4M | $106.3M | $108.6M | $110.5M | $104.8M | $97.9M | $90.8M | ||
| Shares Outstanding | $99.8M | $101.1M | $102.7M | $104.3M | $106.2M | $107.4M | $102.3M | $100.0M | $95.1M | $87.0M | ||
| Basic EPS | $-1.88 | -- | $1.09 | $-2.24 | $3.8 | $8.55 | $3.84 | $6.01 | $33.02 | $15.61 | ||
| Basic EPS (Continuing Operations) | $-1.88 | $-7 | $1.06 | $-2.35 | $3.8 | $8.56 | $3.83 | $6.01 | $33.02 | $15.61 | ||
| Diluted EPS | $-1.88 | -- | $1.07 | $-2.24 | $3.75 | $8.42 | $3.79 | $5.71 | $32.7 | $15.49 | ||
| Diluted EPS (Continuing Operations) | $-1.88 | $-7 | $1.04 | $-2.35 | $3.75 | $8.43 | $3.78 | $5.71 | $32.7 | $15.49 | ||
| OTHER METRICS | ||||||||||||
| Acquisition Expense | -- | -- | -- | $6.0M | $14.0M | $20.0M | $14.0M | -- | -- | -- | ||
| Basic Discontinuous Operations | $-0.05 | -- | $0.03 | $0.11 | -- | $-0.01 | $0.01 | -- | -- | -- | ||
| Depletion | -- | -- | -- | -- | -- | -- | -- | -- | -- | $863.0M | ||
| Diluted Discontinuous Operations | $-0.05 | -- | $0.03 | $0.11 | -- | $-0.01 | $0.01 | -- | -- | -- | ||
| Earnings from equity interest | $131.0M | $144.0M | $150.0M | $175.0M | $169.0M | $218.0M | $216.0M | $228.0M | $260.0M | $264.0M | ||
| Earnings From Equity Interest Net Of Tax | $131.0M | $144.0M | $150.0M | $175.0M | $169.0M | $218.0M | $216.0M | $228.0M | $260.0M | $264.0M | ||
| Gains Loss On Disposal Of Discontinued Operations | $-5.0M | -- | $3.0M | $-4.0M | -- | -- | -- | -- | -- | -- | ||
| Minority Interests | $-368.0M | $-384.0M | $-355.0M | $-386.0M | $-369.0M | $-562.0M | $-590.0M | $-700.0M | $-864.0M | $-960.0M | ||
| Net Income Discontinuous Operations | $-5.0M | -- | $3.0M | $11.0M | $-76.0M | $-1.0M | $1.0M | -- | -- | -- | ||
| Non Recurring Operation Expense | $293.0M | $23.0M | $38.0M | $141.0M | $44.0M | $116.0M | $70.0M | $47.0M | $35.0M | $64.0M | ||
| Other Gain Loss From Disposition Of Discontinued Operations | -- | -- | -- | $15.0M | $-76.0M | $-1.0M | $1.0M | -- | -- | -- | ||
| Other Gand A | $-335.0M | $3.1B | $3.0B | -- | -- | -- | -- | -- | -- | -- | ||
| Other Impairment Of Capital Assets | $-19.0M | $-31.0M | $-4.0M | $16.0M | $76.0M | -- | -- | -- | -- | -- | ||
| Other Write Down | -- | -- | -- | -- | -- | -- | -- | -- | $818.0M | -- | ||
| Other Write Off | -- | -- | -- | -- | -- | -- | -- | $870.0M | -- | -- | ||
| Rent And Landing Fees | $-335.0M | $-340.0M | $-326.0M | -- | -- | -- | -- | -- | -- | -- | ||
| Write Down | $-54.0M | $-364.0M | $-40.0M | -- | -- | -- | -- | -- | -- | -- | ||
| Restruct | $-202.0M | $-541.0M | $-115.0M | $137.0M | $184.0M | $57.0M | $118.0M | $870.0M | -- | -- | ||
Financial data is updated quarterly and may not reflect the most recent earnings.
| A | B | C | D | |
|---|---|---|---|---|
| 1 | Symbol | Price | Change | Vol |
| 2 | THC | $174.79 | +0.6% | 409.27K |
| 3 | ||||
| 4 | ||||
| 5 | ||||
| 6 |
Get Tenet Healthcare Corporation Data in Excel
Stream real-time data directly to your spreadsheets
BUY NOW